Conclusion

Puncia granatum peel extracts HPLC fractions exhibited potential inhibitory activity against MDR bacterial human pathogens. Several bioactive compounds were identified from the HPLC fractions. Further characterization of these compounds may be helpful to conclude it as therapeutic lead molecules against MDR pathogens.

Medicinal plants are widely used as herbal medicine. More than half of world population in Asia, Latin America and Africa uses medicines from plants origin [1, 2]. Traditional medicines are available in the form of powder, pastes, decoction, infusion and pills for the treatment of various human diseases [3, 4]. Most of the plants are naturally producing a wide verity of bioactive molecules that can be obtained from different parts of the plants and used as antibacterial agents [5, 6].

Recent emergence of drug resistance in bacteria revival search to explore alternative strategy to develop new antibacterial compounds [7]. Puncia granatum commonly known as pomegranate, and the peel extract has many beneficial effects including antiviral, immune modulation, diuretic and anthelmintic [8]. According to Dahham et al. P. granatum peel extract has both antibacterial and antifungal activity [9].

Antibacterial activity of P. granatum peel extracts is already reported but these studies not concluding about the bioactive compounds which have anti-MDR activity. In the present study, gradient HPLC fractions were prepared and only those fractions with antibacterial potential were processed for LC MS/MS analysis to identify bioactive compounds. Findings of the study will be helpful for further elucidation of lead molecules from P. granatum for possible therapeutic applications.

The current study was undertaken to document the antibacterial activity of P. granatum chromatographic fractions against multidrug resistant (MDR) pathogenic bacteria isolates at the Department of Microbiology, Kohat University of Science and Technology (KUST), Kohat.

Collection and processing of medicinal plants

P. granatum (peel extract) plant was collected from Charsadda, Khyber Pakhtunkhwa, Pakistan, and identified at the Herbarium of Botany Department, KUST, where the voucher specimen was deposited under reference number 10051/PG. Plant was subjected to grinding process as described [10]. Briefly P. granatum was first washed with tap water, air dried and then chopped into small pieces. After cutting and slicing the collected plant pieces were dried for further processing.

Preparation of P. granatum extracts

Following grinding process, extraction was done as described [11]. Briefly, 1000 g of plant dried powder was soaked in 4 L of all selected solvent (aqueous, chloroform, ethanol and hexane) and incubated it for three weeks. Following filtration, plant’s extracts were then processed in rotary evaporator at 44 °C.

Gradient HPLC fractionation of P. granatum extract

Solidified extracts (hexane ethanol, chloroform and aqueous) of plants were processed for HPLC fractionation by dissolving in 60% methanol as described previously [12]. Briefly, one gram of dried plant powder was dissolved in 10 mL of 60% methanol and centrifuged at 40000 rpm for 5 min. After centrifugation, filtration was done twice for each sample. Before samples subjected to HPLC separation, the column was washed with 60% methanol. Then chromatographic fractionation was done using the PerkinElmer LC technology of C-18 column. This HPLC system configure with Flexar Isocratic LC Pump (N2910400), Flexar solvent Manager (N2600581), 3-cannal Vacuum Degassing and analytical tubing kit (N2910430). HPLC system default pressure was set at 2000 psi, while fractionation was done under 1820–1950 psi pressure and wavelength at 250 nm. About 30 HPLC fractions were multiply collected and analysed.

Collection of multidrug resistant (MDR) bacteria

Pure cultures of the MDR human pathogens [13] were obtained from the Department of Microbiology, KUST and confirmed on the basis of culture, microscopy and biochemical assays.

Antibacterial activity of HPLC fractions of P. granatum

Overnight fresh cultures (adjusted to standard of 0.5 McFarland turbidity) were inoculated on Muller Hinton agar. In each plate, three HPLC fractions of P. granatum plant with negative control (DMSO) were poured in separate well. Antibiotic disc Ceftriaxone (CRO) was incorporated as positive control. All the plates were incubated at 37 °C for 24 h and interpreted the results as per guidelines [14].

LC MS/MS analysis

The fractions, exhibited antimicrobial activity, were further processed for identification of bioactive compounds by LC MS/MS (LTQ XL, Thermo Electron Corporation, USA) analysis as described earlier [15]. The detection was performed through direct injection mode with Electron Spray Ionization (ESI) probe, at positive-mode. The capillary temperature was kept at 280 °C, while the sample flow rate was set at 8 μL/min. The mass range was selected from 50 to 1000 m/z. The collision induced dissociation energy (CID) during MS/MS was kept in the range of 10 to 45, depending upon the nature of parent molecular ion. As a mobile phase, the ratio of methanol and acetonitrile was 80:20 (v/v) for the HPLC fractions of P. granatum. The MS parameters for each compound were optimized to ensure the most favorable ionization, ion transfer conditions and attained optimum signal of both the precursor and fragment ions by infusing the analytes and manually turning the parameters. The source parameters were identical for all of the analytes.

Bioinformatics and data analysis

Chemical structure and other parameters for each compound was searched using online database software (www.chemspider.com). The Xcalibur 2.2 software (Thermo Fisher Scientific, USA) was used for data acquisition and analysis.

Those fractions which have antibacterial activity were processed for identification of bioactive compounds using LC MS/MS analysis. F1 and F4 from aqueous extract of Puncia granatum were identified as valoneic acid dilactone. However, F4 from ethanol extract of P. granatum plant explored as monogalloyl-hexoside and hexahydroxydiphenoyl-hexoside (HHDP-hexoside). Similarly F2 of hexane extract have the presence of coumaric acid (Figs. 1, 2, 3). All the chemical characteristics of identified compounds are listed in Table 2.

Processing a single plant in different formulations may show excellent results against different pathogens and can be used to cure a wide range of diseases. However, medicinal plant has various bioactive components, so they are needed to be separated on HPLC and then tested for antimicrobial activity [16]. Previously no data is available on the HPLC fractionation of P. granatum but many previous studies evaluated the antimicrobial potential of P. granatum extracts.

HPLC fractions of P. granatum plant were evaluated for activity against MDR human bacteria pathogens. It was observed that aqueous extract of HPLC F1 and F4 were effective against E. coli, A. baumannii and P. aeruginosa. This reflects solubility of valuable compounds of P. granatum in aqueous extract.

Chromatographic fractions (F1, F2, F3, and F4) of hexane extract showed anti-MDR activity against A. baumannii, P. aeruginosa, S. aureus and E. coli. Among these fractions, F2 exhibited maximum activity against S. aureus (Gram positive) and P. aeruginosa (Gram negative), while F4 of ethanol was only effective against A. baumannii. In a previous study bioactive compounds of P. granatum were extracted using aqueous, methanol, ethanol, acetone, ether and chloroform solvents. However, in a study the water soluble alkaline fractions contain the highest number of phenolic acids and they were most effective against Gram positive bacteria [17]. Martinsa et al. also revealed that the antibacterial activity of fractions from Larrea tridentata were more effective by inhibiting the growth of Gram-positive bacteria when compare with Gram-negative bacteria [18].

HPLC fractions which were positive for antibacterial activity were further processed for LC MS/MS analysis for compound identification. It was found that aqueous extract by gradient HPLC, F1 and F4, were identified as Valoneic acid dilactone by means of LC MS/MS appeared to be more effective against Gram negative MDR bacteria. Valoneic acid dilactone has antimicrobial potential and is already reported in methanolic extracts of Lagerstroemia speciosa leaves [19].

HPLC fractions of Puncia granatum peel extracts showed inhibitory activity against the clinical MDR isolates. The present study has for the first time identified bioactive compounds from HPLC fractions of P. granatum. Further elucidation of these compounds may be helpful to search new alternative biotherapeutics against MDR pathogens.

Funding

We are thankful to the Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia, for funding the work through the research Group project No RGP-VPP-210.

Availability of data and materials

All data and materials are described within the article.

Authors’ contributions

IK and HR designed the study, carried out the experiments, analyzed the data and drafted the manuscript. NMA, AT and AH helped in the experiments, interpreted the results and drafted the manuscript. TAK, UAK, and MQ analyzed the data and drafted the manuscript. MA, AA, WM, AJ, NM and RU contributed in plant selection, results interpretation and discussion. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

This section is not applicable in this research.

Ethics approval and consent to participate

This section is not applicable in this research.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.